WP Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.46M | Sell |
34,313
-112
| -0.3% | -$24.8K | 1.93% | 14 |
|
|
2025
Q4 | $7.87M | Sell |
34,425
-99
| -0.3% | -$22.6K | 1.96% | 14 |
|
|
2025
Q3 | $7.99M | Buy |
34,524
+177
| +0.5% | +$36K | 2.03% | 13 |
|
|
2025
Q2 | $6.38M | Buy |
34,347
+487
| +1% | +$90.5K | 1.75% | 16 |
|
|
2025
Q1 | $7.09M | Buy |
33,860
+96
| +0.3% | +$18.7K | 2.36% | 12 |
|
|
2024
Q4 | $6M | Buy |
33,764
+349
| +1% | +$64.2K | 2% | 14 |
|
|
2024
Q3 | $6.6M | Sell |
33,415
-2,066
| -6% | -$386K | 2.41% | 10 |
|
|
2024
Q2 | $6.09M | Sell |
35,481
-113
| -0.3% | -$18.7K | 1.94% | 16 |
|
|
2024
Q1 | $6.48M | Sell |
35,594
-145
| -0.4% | -$25K | 2.13% | 15 |
|
|
2023
Q4 | $5.54M | Sell |
35,739
-243
| -0.7% | -$35.4K | 2.05% | 12 |
|
|
2023
Q3 | $5.36M | Buy |
35,982
+295
| +0.8% | +$43.3K | 2.22% | 13 |
|
|
2023
Q2 | $4.81M | Sell |
35,687
-775
| -2% | -$114K | 1.92% | 13 |
|
|
2023
Q1 | $5.81M | Buy |
36,462
+153
| +0.4% | +$23.4K | 2.4% | 12 |
|
|
2022
Q4 | $5.87M | Sell |
36,309
-335
| -0.9% | -$51.4K | 2.62% | 11 |
|
|
2022
Q3 | $4.92M | Buy |
36,644
+444
| +1% | +$63.7K | 2.23% | 14 |
|
|
2022
Q2 | $5.54M | Buy |
36,200
+81
| +0.2% | +$12.4K | 2.41% | 12 |
|
|
2022
Q1 | $5.86M | Sell |
36,119
-1,400
| -4% | -$203K | 2.41% | 11 |
|
|
2021
Q4 | $5.08M | Sell |
37,519
-221
| -0.6% | -$26.1K | 2.12% | 11 |
|
|
2021
Q3 | $4.07M | Sell |
37,740
-437
| -1% | -$49.9K | 1.67% | 11 |
|
|
2021
Q2 | $4.3M | Sell |
38,177
-294
| -0.8% | -$33.1K | 1.79% | 12 |
|
|
2021
Q1 | $4.16M | Buy |
38,471
+1,394
| +4% | +$149K | 1.8% | 14 |
|
|
2020
Q4 | $3.97M | Buy |
37,077
+308
| +0.8% | +$29.6K | 1.92% | 14 |
|
|
2020
Q3 | $3.22M | Buy |
36,769
+7,103
| +24% | +$669K | 1.94% | 12 |
|
|
2020
Q2 | $2.91M | Buy |
29,666
+1,303
| +5% | +$115K | 2.05% | 10 |
|
|
2020
Q1 | $2.16M | Sell |
28,363
-220
| -0.8% | -$18.7K | 2.1% | 8 |
|
|
2019
Q4 | $2.53M | Sell |
28,583
-1,162
| -4% | -$96.5K | 2.61% | 11 |
|
|
2019
Q3 | $2.25M | Sell |
29,745
-4,490
| -13% | -$308K | 2.58% | 11 |
|
|
2019
Q2 | $2.49M | Buy |
34,235
+1,981
| +6% | +$156K | 2.78% | 11 |
|
|
2019
Q1 | $26K | Buy |
32,254
+92
| +0.3% | +$7.53K | 2.83% | 10 |
|
|
2018
Q4 | $2.96M | Sell |
32,162
-313
| -1% | -$27.5K | 2.92% | 11 |
|
|
2018
Q3 | $3.07M | Sell |
32,475
-424
| -1% | -$40.2K | 2.86% | 10 |
|
|
2018
Q2 | $3.05M | Buy |
32,899
+192
| +0.6% | +$18.8K | 2.88% | 11 |
|
|
2018
Q1 | $3.1M | Sell |
32,707
-5,400
| -14% | -$593K | 3.34% | 11 |
|
|
2017
Q4 | $3.69M | Sell |
38,107
-2,647
| -6% | -$249K | 3.57% | 10 |
|
|
2017
Q3 | $3.62M | Sell |
40,754
-427
| -1% | -$32.5K | 2.73% | 13 |
|
|
2017
Q2 | $2.99M | Sell |
41,181
-2,047
| -5% | -$138K | 2.16% | 15 |
|
|
2017
Q1 | $2.82M | Buy |
43,228
+2,130
| +5% | +$134K | 1.77% | 15 |
|
|
2016
Q4 | $2.57M | Buy |
+41,098
| New | +$2.51M | 1.8% | 16 |
|
Other funds holding ABBV
VCM
VPM
WP Advisors's ABBV Position: Q1 2026 in Review
WP Advisors reduced its AbbVie (ABBV) stake by 0.33% in Q1 2026, selling an estimated $24.8K and leaving 34,313 shares worth $7.46M. The position accounts for 1.93% of the portfolio, ranked #14.
WP Advisors first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $7.99M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- WP Advisors held 34,313 shares of AbbVie worth $7.46M as of Q1 2026.
- WP Advisors sold 112 AbbVie shares in Q1 2026, an estimated $24.8K.
- AbbVie made up 1.93% of WP Advisors's portfolio in Q1 2026, its #14 holding.
- WP Advisors first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
- WP Advisors's AbbVie position peaked at $7.99M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on WP Advisors's 13F filing for Q1 2026, filed 4 May 2026.